by Truveta Staff | Mar 18, 2024 | Research, Technology
Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout February 2024 (-20.0%) compared to January 2024. While COVID- and influenza-associated hospitalizations decreased (-26.5% and -22.7%), all other respiratory viruses...
by Truveta Staff | Feb 23, 2024 | Research, Technology
Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout January 2024 (-35.3%) compared to December 2023. The largest decreases were seen in parainfluenza virus- (-49.0%), RSV- (-48.0%), and influenza-associated (-41.6%)...
by Truveta Staff | Jan 26, 2024 | Research, Technology
Truveta Research explored the rates of pediatric RSV immunizations and pediatric RSV-associated hospitalizations for children under the age of two. Of the 1,872,292 children under age two who were eligible to receive an RSV immunization, 3.7% of the eligible...
by Truveta Staff | Jan 23, 2024 | Research, Technology
Overall, the rate of hospitalizations associated with respiratory viruses continues to increase (92.8% increase from November 2023 to the end of December 2023). The largest increases in hospitalizations over the past month were associated with influenza (251.7%...
by Truveta Staff | Dec 15, 2023 | Technology
As 2023 draws to a close and we reflect on a busy and exciting year for Truveta, something that stands out is the breadth and depth of research Truveta Research has been able to produce using Truveta Data and Truveta Studio. From studying new Alzheimer’s disease...